AlenCiken

New data independently confirms and extends laboratory findings

NASDAQ:ATHE   ALTERITY THERAPEUTICS LIMITED
New data independently confirms and extends laboratory findings and expands safety profile of ATH434

new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of Parkinson's Disease and Movement Disorders ( MDS 2020) and the American Neurological Association's 2020 Annual Meeting (ANA 2020).


both conferences will be held in a virtual format with MDS 2020 being held 12-16th September, and ANA 2020 to be held 4-9th October.

https://finance.yahoo.com/news/data-inde...


Comments

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Private Messages Chat Sign Out